CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 192309-192593 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/CORD-19/sourceid/2008f024274c53b0de1276f4047a6a641813fd98","sourcedb":"CORD-19","sourceid":"2008f024274c53b0de1276f4047a6a641813fd98","text":"We have previously reported Th1 and Th2 cytokine alterations associated with several clinical entities that had overlapping disease manifestations affecting the mucosal-associated lymphoid tissues (MALT), of the GI tract (GALT), skin (SALT), nasal (NALT) and bronchial tissues (BALT).","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T86353","span":{"begin":0,"end":284},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T86353","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"Epistemic_Statements","denotations":[{"id":"T342","span":{"begin":0,"end":284},"obj":"Epistemic_statement"}],"attributes":[{"subj":"T342","pred":"source","obj":"Epistemic_Statements"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T447","span":{"begin":0,"end":284},"obj":"Sentence"}],"attributes":[{"subj":"T447","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T367","span":{"begin":180,"end":196},"obj":"Body_part"},{"id":"T368","span":{"begin":229,"end":233},"obj":"Body_part"}],"attributes":[{"id":"A367","pred":"uberon_id","subj":"T367","obj":"http://purl.obolibrary.org/obo/UBERON_0001744"},{"id":"A368","pred":"uberon_id","subj":"T368","obj":"http://purl.obolibrary.org/obo/UBERON_0000014"},{"subj":"T367","pred":"source","obj":"CORD-19-PD-UBERON"},{"subj":"T368","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ec93c6","default":true},{"id":"Epistemic_Statements","color":"#93e0ec"},{"id":"CORD-19_Custom_license_subset","color":"#ecde93"},{"id":"CORD-19-PD-UBERON","color":"#c493ec"}]}]}}